Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that proper treatment and management of plaque psoriasis in adolescents can improve their quality of life.

Cicatricial alopecia involves scarring hair loss and can be treated with various medications.

Biologics and JAK inhibitors may improve treatment for scarring alopecias.

Hair loss due to scalp metastasis from breast cancer, known as Neoplastic Alopecia, has a better survival rate than other scalp metastases and requires a biopsy for diagnosis.

Hair loss in men is mainly caused by hormones and genes, and while current treatments can slow it down, they can't fully stop it.

Platelets and their derivatives, like PRP, can help tissue regeneration, but need standardized safety protocols.

Early balding, premature graying, and hair thinning can predict heart disease in young Asian males.

Best treatment for Frontal Fibrosing Alopecia is 5-alpha-reductase inhibitors and intralesional corticosteroids.

Early diagnosis and aggressive treatment are crucial for Cicatricial Alopecia, and treatment effectiveness varies among patients.

The document suggests a possible link between mast cells and scarring alopecia, recommending more research for potential treatments.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

Hair loss linked to kidney stones in people under 60.

Stopping infliximab and using strong topical steroids can regrow hair lost due to psoriasiform alopecia.

The document concludes that diagnosing and managing plaque psoriasis, particularly in sensitive areas, is challenging and requires careful differentiation from similar skin conditions.

Finasteride lowers good cholesterol, raises bad fats, and may increase heart disease risk.

Early and aggressive treatment of scarring alopecia is important to prevent further hair follicle damage.

No single treatment for androgenetic alopecia exists, but available options are generally satisfying.

The document concludes that more research is needed on treatments for hair loss in both men and women, especially on medication combinations and their benefits.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

The document concludes that more research is needed to better understand and treat scarring hair loss conditions.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

Early detection and treatment are crucial to prevent permanent hair loss in children with pressure alopecia.

Reduced alpha smooth muscle actin may cause hair loss in androgenetic alopecia.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Hair loss in Lichen Planopilaris is caused by immune system issues damaging hair follicles and stem cells.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Rituximab treatment led to complete hair regrowth and improved skin in a woman with pemphigus foliaceus.

Trichoscopy effectively diagnoses and monitors cicatricial alopecias, reducing the need for biopsies.